Implantable intrathecal pumps for the treatment of noncancer chronic pain in elderly population: Drug dose and clinical efficacy

Neuromodulation

Volumn 11, Issue 1, 2008, Pages 33-39

  Raffaeli, William ^a   Righetti, Donatella ^a   Caminiti, Alessandro ^a   Ingardia, Alessandro ^b   Balestri, Marco ^a   Pambianco, Lucia ^c   Fanelli, Guido ^c   Facondini, Francesca ^b   Pantazopoulos, Pantazis ^b  

^a Infermi Hospital   (Italy)

^b Department of Anesthesiology and Intensive Care ^*  (Italy)

^c UNIVERSITY OF PARMA   (Italy)

Author keywords

IT therapy; Noncancer chronic pain; Pain management

Indexed keywords

BUPIVACAINE; MORPHINE; SODIUM CHLORIDE;

AGED; ANOREXIA; ARTICLE; CARDIOTOXICITY; CHRONIC PAIN; CLINICAL ARTICLE; CONSTIPATION; CONTINUOUS INFUSION; DIARRHEA; DISEASE SEVERITY; DIZZINESS; DROWSINESS; DRUG DELIVERY SYSTEM; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; HUMAN; HYPOTENSION; IMPOTENCE; LOW DRUG DOSE; MALE; MINIPUMP; NAUSEA; NEUROPATHIC PAIN; PAIN ASSESSMENT; PRURITUS; QUALITY OF LIFE; QUESTIONNAIRE; URINE RETENTION; VISUAL ANALOG SCALE; VOMITING; XEROSTOMIA;

EID: 37549005585     PISSN: 10947159     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-1403.2007.00140.x     Document Type: Article

References (26)

1. Chambers FA, MacSullivan R. Intrathecal morphine in the treatment of chronic intractable pain. Ir J Med Sci 1994 163 : 318 321.
2. Krames E. The chronic intraspinal use of opioid and local anesthetic mixtures for the relief of intractable pain: when all else fails! Pain 1993 55 : 1 4.
3. Nordberg G, Hedner T, Mellstrand T, Dahlstrom B. Pharmacokinetic aspects of intrathecal morphine analgesia. Anesthesiology 1984 60 : 448 454.
4. Sullivan ARF, McQuay HJ, Bailey D, Dickenson AH. The spinal antinociceptive actions of morphine metabolites: morphine-6-glucuronide and normorphine in the rat. Brain Res 1989 482 : 219 224.
5. Li DF, Bahar M, Cole G, Rosen M. Neurological toxicity of the subarachnoid infusion of bupivacaine, lignocaine or 2-chloroprocaine in the rat. Br J Anaesth 1985 57 : 424 429.
6. Dahm P, Nitescu P, Appelgren L, Curelaru I. Efficacy and technical complications of long-term continuous intraspinal infusions of opioid and/or bupivacaine in refractory nonmalignant pain: a comparison between the epidural and the intrathecal approach with externalized or implanted catheters and infusion pumps. Clin J Pain 1998 14 : 4 16.
7. Krames ES, Lanning RM. Intrathecal infusional analgesia for nonmalignant pain: analgesic efficacy of intrathecal opioid with or without bupivacaine. J Pain Symptom Manage 1993 8 : 539 548.
8. Sjoberg M, Appelgreen L, Einarsson S et al. Long-term intrathecal morphine and bupivacaine in refractory cancer pain. I. Results from the first series of 52 patients. Acta Anaesthesiol Scand 1991 35 : 30 43.
9. Hassenbusch SJ, Portenoy RK. Current practices in intraspinal therapy - a survey of clinical trends and decision making. J Pain Symptom Manage 2000 20 : 4 11.
10. Brody JA, Schneider EL. Age dependent and age related disease. J Chronic Dis 1956 39 : 11 871.
11. Chodosh J, Solomon D, Roth OP. The quality of medical care provided to vulnerable older patients with chronic pain. J Am Geriatr Soc 2004 52 : 756 771.
12. Holford NHG, Sheiner LB. Pharmacokinetic and dynamic modelling in vivo. CRC Crit Rev Bioeng 1981 5 : 273 322.
13. Moffat JA, Milne B. pharmacokinetics in anaesthesia. Can Anaesth Soc J 1983 30 : 300 307.
14. Hilgenberg JC. Inhalation and intravenous drugs in the elderly patient. Semin Anesth 1986 5 : 44 53.
15. Winkelmuller M, Winkelmuller W. Long-term effects of continuous intrathecal opioid treatment in chronic pain of non malignant etiology. J Neurosurg 1996 85 : 458 467.
16. Brown J, Klapon J, Doleys D, Lowery D, Tutak U. Disease-specific and generic health outcomes a model for the evaluation of long-term intrathecal opioid therapyin noncancer low back pain patients. Clin J Pain 1999 15 : 122 131.
17. Roberts LJ, Finch PM, Croucke CR, Price LM. Outcome of intrathecal opioids in chronic non cancer pain. Eur J Pain 2001 5 : 353 361.
18. Anderson VC, Burchiel KJ, A. prospective study of long-term intrathecal morphine in the management of chronic nonmalignant pain. Neurosurgery 1999 44 : 289 301.
19. Hassenbusch SJ, Stanton-Hicks M, Covington EC, Walsh JG, Guthrey DS. Long term intraspinal infusions of opioids in the treatment of neuropathic pain. J Pain Symptom Manage 1995 10 : 527 543.
20. Tutak U, Doleys DM. Intrathecal infusion systems for treatment of chronic low back and leg pain of noncancer origin. South Med J 1996 89 : 295 300.
21. Willis KD, Doleys DM. The effects of long-term intraspinal infusion therapy with non cancer pain patients: evaluation of patients, significant-other and clinic staff appraisals. Neuromodulation 1999 2 : 241 253.
22. Franco Gay ML. Spinal morphine in nonmalignant chronic pain: a retrospective study in 39 patients. Neuromodulation 2002 5 : 150 159.
23. Paice JA, Penn RD, Shott S. Intraspinal morphine M for chronic pain: a retrospective, multicenter study. J Pain Symptom Manage 1996 11 : 71 80.
24. Doleys DM, Coleton M, Tutak U. Use of intraspinal infusion therapy with non cancer patients: follow-up and comparison of worker's compensation vs. non-worker's compensation patients. Neuromodulation 1998 1 : 149 159.
25. Naumann C, Erdine S, Koulousakis A, Van Buyten JP, Schuchard M. Drug adverse events and system complications of intrathecal opioid delivery for pain: origins, detection, manifestations and management. Neuromodulation 1999 2 : 92 107.
26. Hassenbusch ST, Stanton-Hicks MD, Soukup J, Covington EC, Boland MB. Sufentanil citrate and morphine/bupivacaine as alternative agents in chronic epidural infusions for intractable non cancer pain. Neurosurgery 1991 29 : 76 82.